Cargando…
Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection
Immune thrombocytopenic purpura (ITP) has been linked to the COVID-19 vaccine series as a rare adverse event but has recently emerged in the literature as a sequela of natural COVID-19 infection. ITP is a diagnosis of exclusion where a diagnosis is made by having isolated thrombocytopenia (platelet...
Autores principales: | Santhosh, Sisira, Malik, Bilal, Kalantary, Atefeh, Kunadi, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270081/ https://www.ncbi.nlm.nih.gov/pubmed/35815306 http://dx.doi.org/10.7759/cureus.26582 |
Ejemplares similares
-
Immune Thrombocytopenic Purpura Following COVID-19 Infection: A Case Report and Literature Review
por: Nguyen, Hien, et al.
Publicado: (2023) -
A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
por: Kandah, Emad, et al.
Publicado: (2021) -
Update on chronic immune thrombocytopenic purpura (ITP)
por: McMillan, Robert
Publicado: (2009) -
Helicobacter pylori: An Underrated Cause of Immune Thrombocytopenic Purpura. A Comprehensive Review
por: Zain, Muhammad A, et al.
Publicado: (2019) -
Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine
por: Malik, Bilal, et al.
Publicado: (2021)